copper histidinate 2.9 MG Injection [Zycubo]
- RxCUI
- 2732224
- RxNorm name
- copper histidinate 2.9 MG Injection [Zycubo]
- Display name
- copper histidinate 2.9 MG Injection [Zycubo]
- Full name
- copper histidinate 2.9 MG Injection [Zycubo]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:25
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zycubo | COPPER HISTIDINATE | Sentynl Therapeutics, Inc. | e3aeefc2-f44d-4337-9c2e-3dba44a89e48 | 2026-01-12 | Warnings, Adverse reactions | 2732224 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e3aeefc2-f44d-4337-9c2e-3dba44a89e48 | ZYCUBO 2.9 MG Injection [PSN] · copper histidinate 2.9 MG Injection [Zycubo] [SBD] · Zycubo 2.9 MG Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use ZYCUBO safely and effectively. See full prescribing information for ZYCUBO. ZYCUBO ® (copper histidinate) for injection, for subcutaneous use Initial U.S. Approval: 2026 | 20260112 |